| This week's sponsor is Ajinomoto Bio-Pharma Services. | | | |
Today's Rundown Karuna hires another ex-Lilly scientist in quest to resurrect Alzheimer’s drug BioNTech lines up $800M Nasdaq IPO to fuel mRNA R&D: Reuters With NCI Director Sharpless in as interim FDA head, what does that mean for interagency cooperation? [Sponsored] Incorporating The Patient Voice To Improve Ulcerative Colitis Recruitment Akebia’s Japanese vadadustat data ‘bode well’ for larger trials: analysts Deerfield ponies up $100M for translational research deal with Harvard Featured Story | | | Wednesday, March 13, 2019 Christian Felder has joined Karuna Pharmaceuticals as VP of discovery research. The appointment reunites Felder with xanomeline, a once-failed Alzheimer’s disease drug he helped through early development while at Eli Lilly. |
|
|
Top Stories Wednesday, March 13, 2019 BioNTech is lining up a Nasdaq IPO that could raise $800 million, according to Reuters. The German mRNA specialist is reportedly planning to fuel its cash-intensive plans by following rival Moderna on to public markets. Tuesday, March 12, 2019 The announcement that NCI Director Ned Sharpless will take on the role of acting commissioner of the FDA has raised some intriguing speculation about the possibilities for interagency cooperation between the federal government’s main medical research and innovation arm and its industry regulator. Monday, March 11, 2019 Strengthen Your Protocol With Patient Insights. See how Covance helps sponsors reduce patient burden to increase participation and improve patient retention. Wednesday, March 13, 2019 Though the Japanese data aren’t a perfect predictor of what might happen in vadadustat’s global registrational studies, Piper Jaffray analysts called them “a nice proxy” for those trials, which are expected to read out in 2020. Wednesday, March 13, 2019 Deerfield Management and Harvard University are setting up a new company dubbed Lab1636, with $100 million in backing from Deerfield. In addition to funding research on campus, Lab1636 will support R&D projects, which could include helping teams validate targets or out-license their work to other companies. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: ON24 Which HCP Touchpoints and channels are yielding the best results in today’s digital world? Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. BioBasics: Biotech For The Non-Scientist March 28-29, 2019 | Boston, MA Drug Development Immersion April 3-4, 2019 | Philadelphia, PA 2019 BIO International Convention June 3-6, 2019 | Philadelphia, PA Calling Europe – Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 